First Time Loading...

Dyadic International Inc
NASDAQ:DYAI

Watchlist Manager
Dyadic International Inc Logo
Dyadic International Inc
NASDAQ:DYAI
Watchlist
Price: 1.49 USD Market Closed
Updated: Apr 29, 2024

Dyadic International Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Dyadic International Inc
Revenue Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Dyadic International Inc
NASDAQ:DYAI
Revenue
$2.9m
CAGR 3-Years
22%
CAGR 5-Years
17%
CAGR 10-Years
-16%
Abbvie Inc
NYSE:ABBV
Revenue
$54.3B
CAGR 3-Years
6%
CAGR 5-Years
11%
CAGR 10-Years
11%
Gilead Sciences Inc
NASDAQ:GILD
Revenue
$27.1B
CAGR 3-Years
3%
CAGR 5-Years
4%
CAGR 10-Years
9%
Amgen Inc
NASDAQ:AMGN
Revenue
$28.2B
CAGR 3-Years
4%
CAGR 5-Years
3%
CAGR 10-Years
4%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Revenue
$9.9B
CAGR 3-Years
17%
CAGR 5-Years
26%
CAGR 10-Years
23%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Revenue
$13.1B
CAGR 3-Years
16%
CAGR 5-Years
14%
CAGR 10-Years
20%

Dyadic International Inc
Revenue Breakdown

Breakdown by Geography
Dyadic International Inc

Not Available

Breakdown by Segments
Dyadic International Inc

Total Revenue: 2.9m USD
100%
Research And Development: 2.5m USD
87.8%
License: 352.9k USD
12.2%

See Also

What is Dyadic International Inc's Revenue?
Revenue
2.9m USD

Based on the financial report for Dec 31, 2023, Dyadic International Inc's Revenue amounts to 2.9m USD.

What is Dyadic International Inc's Revenue growth rate?
Revenue CAGR 10Y
-16%

Over the last year, the Revenue growth was -1%. The average annual Revenue growth rates for Dyadic International Inc have been 22% over the past three years , 17% over the past five years , and -16% over the past ten years .